QS Investors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$8.64M Buy
13,680
+945
+7% +$522K 0.1% 148
2021
Q1
$6.23M Buy
12,735
+819
+7% +$410K 0.07% 205
2020
Q4
$5.96M Sell
11,916
-1,275
-10% -$570K 0.07% 194
2020
Q3
$5.19M Buy
13,191
+560
+4% +$207K 0.07% 196
2020
Q2
$4.17M Sell
12,631
-832
-6% -$241K 0.06% 260
2020
Q1
$3.26M Sell
13,463
-499
-4% -$130K 0.05% 282
2019
Q4
$3.7M Buy
13,962
+151
+1% +$39.8K 0.04% 369
2019
Q3
$3.76M Sell
13,811
-2,162
-14% -$602K 0.04% 360
2019
Q2
$4.4M Sell
15,973
-1,637
-9% -$403K 0.05% 307
2019
Q1
$3.94M Sell
17,610
-4,093
-19% -$845K 0.04% 341
2018
Q4
$4.04M Buy
21,703
+8,302
+62% +$1.7M 0.05% 284
2018
Q3
$3.35M Buy
13,401
+6,355
+90% +$1.54M 0.03% 423
2018
Q2
$1.54M Sell
7,046
-880
-11% -$181K 0.02% 674
2018
Q1
$1.52M Buy
7,926
+161
+2% +$29.7K 0.02% 668
2017
Q4
$1.21M Buy
7,765
+2,367
+44% +$373K 0.01% 752
2017
Q3
$839K Buy
5,398
+1,330
+33% +$210K 0.01% 835
2017
Q2
$657K Buy
4,068
+60
+1% +$9.74K 0.01% 859
2017
Q1
$620K Buy
4,008
+4,000
+50,000% +$551K 0.01% 900
2016
Q4
$1K Hold
8
﹤0.01% 1629
2016
Q3
$1K Hold
8
﹤0.01% 1613
2016
Q2
$1K Hold
8
﹤0.01% 1652
2016
Q1
$1K Hold
8
﹤0.01% 1649
2015
Q4
$1K Buy
+8
New +$571 ﹤0.01% 1673

Other funds holding IDXX

QS Investors's IDXX Position: Q2 2021 in Review

QS Investors increased its Idexx Laboratories (IDXX) stake by 7.4% in Q2 2021, buying an estimated $522K and bringing the position to 13,680 shares worth $8.64M. The position accounts for 0.1% of the portfolio, ranked #148.

QS Investors first reported a position in IDXX in Q4 2015 and has held it in 23 quarters since. 1,032 funds tracked by Wall St. Rank hold IDXX as of Q2 2021.

  • QS Investors held 13,680 shares of Idexx Laboratories worth $8.64M as of Q2 2021.
  • QS Investors bought 945 Idexx Laboratories shares in Q2 2021, an estimated $522K.
  • Idexx Laboratories made up 0.1% of QS Investors's portfolio in Q2 2021, its #148 holding.
  • QS Investors first reported a position in Idexx Laboratories in Q4 2015 and has held it in 23 quarters since.
  • 1,032 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.